Mangoceuticals, Inc. Diluted Shares Outstanding (Weighted Average)
Mangoceuticals, Inc. (MGRX) reported Diluted Shares Outstanding (Weighted Average) of 17.12 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- Mangoceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 17.12M shares, a 71.48% increase year-over-year.
- Mangoceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 16.48M shares, a 258.84% increase year-over-year.
- Mangoceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 14.19M shares, a 441.42% increase year-over-year.
- Mangoceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 11.52M shares, a 472.25% increase year-over-year.
- Mangoceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 10.07M shares, a 408.93% increase from fiscal 2024.
- Mangoceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 1.98M shares, a 84.23% increase from fiscal 2023.
- Mangoceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 1.07M shares, a 90.05% decline from fiscal 2022.
- Mangoceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 10.80M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 17.12M shares 10-Q · filed 2026-08-13 | 16.80M shares 10-Q · filed 2026-08-13 | 15.93M shares derived: average of 3 quarters · filed 2026-08-13 | 14.83M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 16.48M shares 10-Q · filed 2026-05-19 | 15.34M shares derived: average of 2 quarters · filed 2026-05-19 | 14.06M shares derived: average of 3 quarters · filed 2026-05-19 | 13.04M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 14.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | 12.86M shares derived: average of 2 quarters · filed 2026-04-01 | 11.90M shares derived: average of 3 quarters · filed 2026-08-13 | 10.07M shares 10-K · filed 2026-04-01 | ||||
| 2025-09-30 | 11.52M shares 10-Q · filed 2025-11-14 | 10.75M shares derived: average of 2 quarters · filed 2026-08-13 | 8.70M shares 10-Q · filed 2025-11-14 | 7.18M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 9.98M shares 10-Q · filed 2026-08-13 | 7.28M shares 10-Q · filed 2026-08-13 | 5.73M shares derived: average of 3 quarters · filed 2026-08-13 | 4.80M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 4.59M shares 10-Q · filed 2026-05-19 | 4.59M shares 10-Q · filed 2025-05-15 | 3.61M shares derived: average of 2 quarters · filed 2026-05-19 | 3.08M shares derived: average of 3 quarters · filed 2026-05-19 | 2.74M shares derived: average of 4 quarters · filed 2026-05-19 | |||
| 2024-12-31 | 2.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | 2.32M shares derived: average of 2 quarters · filed 2026-04-01 | 2.12M shares derived: average of 3 quarters · filed 2026-04-01 | 1.98M shares 10-K · filed 2026-04-01 | ||||
| 2024-09-30 | 2.01M shares 10-Q · filed 2025-11-14 | 1.88M shares derived: average of 2 quarters · filed 2025-11-14 | 1.77M shares 10-Q · filed 2025-11-14 | 1.66M shares derived: average of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | 1.74M shares 10-Q/A · filed 2025-11-14 | 26.10M shares 10-Q · filed 2024-08-14 | 1.64M shares 10-Q/A · filed 2025-11-14 | 24.58M shares 10-Q · filed 2024-08-14 | 1.54M shares derived: average of 3 quarters · filed 2025-11-14 | 1.42M shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-03-31 | 1.57M shares 10-Q · filed 2025-05-15 | 22.83M shares 10-Q · filed 2024-05-15 | 1.44M shares derived: average of 2 quarters · filed 2025-05-15 | 1.32M shares derived: average of 3 quarters · filed 2025-05-15 | 4.93M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 1.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 1.19M shares derived: average of 2 quarters · filed 2025-03-20 | 6.05M shares derived: average of 3 quarters · filed 2025-03-20 | 1.07M shares 10-K · filed 2025-03-20 | 16.11M shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 1.06M shares 10-Q · filed 2024-11-14 | 15.92M shares 10-Q · filed 2023-10-27 | 8.42M shares derived: average of 2 quarters · filed 2024-11-14 | 994.90K shares 10-Q · filed 2024-11-14 | 14.92M shares 10-Q · filed 2023-10-27 | 10.39M shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 15.77M shares 10-Q · filed 2024-08-14 | 14.50M shares 10-Q · filed 2024-08-14 | 13.49M shares derived: average of 3 quarters · filed 2024-08-14 | 12.63M shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 11.26M shares 10-Q · filed 2024-05-15 | 12.36M shares derived: average of 2 quarters · filed 2024-05-15 | 11.59M shares derived: average of 3 quarters · filed 2024-05-15 | 10.94M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 13.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 11.75M shares derived: average of 2 quarters · filed 2024-04-01 | 10.84M shares derived: average of 3 quarters · filed 2024-04-01 | 10.80M shares 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | 10.05M shares 10-Q · filed 2023-10-27 | 9.53M shares derived: average of 2 quarters · filed 2023-10-27 | 9.91M shares 10-Q · filed 2023-10-27 | |||||
| 2022-06-30 | 9.01M shares 10-Q · filed 2023-07-28 | 8.82M shares 10-Q · filed 2023-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |